The Empire Liver Foundation, in collaboration with HepCure and the NYC Health Department, are co-sponsoring three clinical education programs starting in February 2022. These programs will feature national experts who will discuss the possibilities of new treatment options for hepatitis B and C and on how COVID impacts people with liver disease. Sign up today for these programs which include free CME/CNE/CEU credits.
Long-Acting Treatments for Infections: Is Hepatitis Next?
Tuesday, February 8, 2022 (4:30-5:30 EST) - 1.0 Free CME/CNE/CEU
Learning Objectives:
Compare use of long-acting treatments for HCV and HBV
List the challenges of making long-acting treatments
Identify the lead compounds for HCV and HBV
Speaker: David Thomas, MD, MPH, Chief Division of Infectious Diseases, Stanhope-Bayne Jones Professor of Medicine, Johns Hopkins School of Medicine
Questions? Contact Meg Chappell at the Empire Liver Foundation at megchappell@empireliverfoundation.org